Home / Business and Economy / Divis Labs Profit Soars 13.4% in Q4 FY26
Divis Labs Profit Soars 13.4% in Q4 FY26
23 May
Summary
- Net profit rose 13.4% year-over-year to Rs 751 crore in Q4 FY26.
- Revenue grew 9.52% year-over-year to Rs 2,831 crore for the quarter.
- A final dividend of Rs 30 per equity share is recommended for FY26.
Divis Laboratories announced robust financial results for the fourth quarter of fiscal year 2026. The company's consolidated net profit experienced a notable 13.4% year-over-year increase, amounting to Rs 751 crore, compared to Rs 662 crore in the corresponding quarter of the previous fiscal year.
Revenue from operations for Q4 FY26 grew by 9.52% to Rs 2,831 crore, up from Rs 2,585 crore in Q4 FY25. Profit before tax also saw an 11.46% rise, reaching Rs 963 crore. Total expenses increased by 11.95% to Rs 2,023 crore.
For the full fiscal year 2026, Divis Laboratories reported a consolidated net profit of Rs 2,568 crore, marking a 17.21% increase over FY25. Full-year revenue climbed 12.82% to Rs 10,560 crore. The company also reported a forex gain of Rs 90 crore in Q4 FY26.
The board has proposed a final dividend of Rs 30 per equity share for FY26, pending shareholder approval at the 36th AGM on August 10, 2026. The record date for dividend eligibility is July 24, 2026. Divis Laboratories is a manufacturer of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients.
